Eiko Lifesciences Ltd Quarterly Results

Gross Sales

11.27

7.49

8.16

10.75

0.84

Excise Duty

0

0

0

0

0

Net Sales

11.27

7.49

8.16

10.75

0.84

Other Operating Income

0

0

0

0

0

Other Income

0.57

0.09

0.13

0.26

0.01

Total Income

11.84

7.58

8.29

11.01

0.85

Total Expenditure

9.96

6.85

7.73

10.36

0.89

PBIDT

1.88

0.73

0.55

0.66

-0.03

Interest

0.07

0.03

0.04

0.03

0.1

PBDT

1.82

0.7

0.52

0.63

-0.14

Depreciation

0.25

0.16

0.16

0.17

0.04

Minority Interest Before NP

0

0

0

0

0

Tax

0.21

0.11

0.07

0.09

0.01

Deferred Tax

0.18

0.03

0.03

0.03

-0.05

Reported Profit After Tax

1.17

0.4

0.26

0.35

-0.13

Minority Interest After NP

0.2

0.01

0

0

-0.08

Net Profit after Minority Interest

1.05

0.41

0.28

0.37

-0.05

Extra-ordinary Items

0.26

0

0

0

0

Adjusted Profit After Extra-ordinary item

0.79

0.41

0.28

0.37

-0.05

EPS (Unit Curr.)

0.8

0.32

0.22

0.29

-0.14

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

13.76

12.87

12.87

12.87

3.82

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.68

9.74

6.74

6.13

-3.57

PBDTM(%)

16.14

9.34

6.37

5.86

-16.66

PATM(%)

10.38

5.34

3.18

3.25

-15.47